查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1957492

2026年全球神经毒素市场报告

Neurotoxin Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，神经毒素市场显着扩张。预计该市场将从2025年的80.3亿美元成长到2026年的87.7亿美元，复合年增长率（CAGR）为9.2%。过去几年的成长归因于以下因素：人们对美容手术的认知度提高、肉毒桿菌毒素在美容治疗中的应用日益广泛、神经系统疾病发病率上升、皮肤科和专科诊所的扩张，以及肉毒桿菌毒素类产品的早期监管核准。

预计未来几年神经毒素市场将维持强劲成长，2030年市场规模将达到124.3亿美元，复合年增长率（CAGR）为9.1%。预测期内的成长要素包括：治疗应用范围从美容手术扩展到其他领域；对非手术医疗的需求不断增长；新一代神经毒素的创新；新兴市场医疗费用支出的增加；以及全球人口老化加剧。预测期内的主要趋势包括：治疗性神经毒素适应症的扩大；对微创美容手术的需求增加；高效精准神经毒素的研发；在慢性偏头痛和痉挛症治疗中的应用日益广泛；以及对安全性、纯度和低免疫抗原性的日益关注。

预计未来几年，人们越来越多地选择美容手术来改善外貌，这将推动神经毒素市场的成长。美容手术涵盖范围广泛，主要目的是改善或改变个人的外观。这一趋势受到社会、技术和文化因素的影响，同时也源于人们对美容手术益处的日益增长的认识。神经毒素广泛应用于美容疗程中，用于放鬆目标肌肉，减少皱纹和细纹。例如，根据美国整形外科医师协会（ASPS，一家总部位于美国的非营利组织）统计，截至2024年6月，微创手术的数量在2023年增长了7%，比外科手术的增长率高出2%。手部手术（包括腕隧道症候群、关节炎和扳机指手术）总数达到207,887例，比2022年增加了2%。因此，旨在改善外观的美容手术数量的增加正在推动神经毒素市场的成长。

神经毒素市场的主要企业正致力于创新研发，例如旨在改善美容效果、拓展治疗选择并提升患者满意度的新一代美容神经毒素。新一代美容神经毒素是基于肉毒桿菌毒素的新型配方，用于减少美容应用中的皱纹，能够实现更精准的肌肉调节、更快的起效速度或更长的持续时间。例如，2023年1月，总部位于美国的医疗美容公司Evoras的Nuceiva（普拉肉毒素A）获得了澳洲药品管理局（TGA）的核准。 Nuceiva（普拉肉毒素A）是一种美容神经毒素，它透过阻断神经讯号来放鬆脸部肌肉，从而减少因脸部表情、瞇眼和皱眉引起的皱纹，适用于暂时改善成年患者的中度皱纹。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球神经毒素市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 永续性、气候技术、循环经济
  • 主要趋势
    • 扩大治疗性神经毒素的适应症
    • 对微创美容手术的需求日益增长
    • 开发高持久性和高精准度的神经毒素
    • 在慢性偏头痛和痉挛的治疗中应用日益广泛
    • 人们越来越关注安全性、纯度和降低免疫抗原性

第五章 终端用户产业市场分析

  • 医院
  • 专科诊所
  • 皮肤科诊所
  • 神经科诊所
  • 整形外科中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球神经毒素市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球神经毒素市场规模、对比及成长率分析
  • 全球神经毒素市场表现：规模与成长，2020-2025年
  • 全球神经毒素市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 依产品类型
  • 肉毒桿菌、Dysport、 Xeomin及其他产品
  • 透过使用
  • 治疗用途，美容用途
  • 最终用户
  • 医院、专科诊所、皮肤科诊所和其他终端用户
  • 按类型细分：肉毒桿菌
  • 美容和治疗用途
  • 按类型细分：Dysport
  • 美容用途，医疗适应症
  • 按类型细分： Xeomin
  • 美容护理，治疗用途
  • 按类型细分：其他产品
  • Jouvaud 和其他新兴神经毒素

第十章 区域与国别分析

  • 全球神经毒素市场：依地区划分，历史资料及预测（2020-2025年、2025-2030年、2035年）
  • 全球神经毒素市场：依国家划分，历史资料及预测（2020-2025年、2025-2030年、2035年）

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 神经毒素市场：竞争格局及市场占有率（2024年）
  • 神经毒素市场：公司估值矩阵
  • 神经毒素市场：公司简介
    • AbbVie Inc.
    • Galderma Inc.
    • Ipsen SA
    • Daewoong Pharmaceutical Co. Ltd.
    • Merz Pharma GmbH & Co KGaA

第37章 其他大型企业和创新企业

  • Hugel Inc., Evolus Inc., Medytox Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., Gufic Biosciences Ltd., Hironic Co. Ltd., Allergan, Lanzhou Institute of Biological Products Co. Ltd., Sinclair Pharma, Vida Aesthetics, Evolife, Hugel Bio, Medytox USA, Revance Aesthetics

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年神经毒素市场：提供新机会的国家
  • 2030年神经毒素市场：新兴细分市场机会
  • 2030年神经毒素市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH4MNEUR05_G26Q1

Neurotoxins are substances that are specifically harmful to nerve cells (neurons) or the nervous system. They function by blocking or disrupting cellular processes within neurons. Neurotoxins are used to temporarily minimize wrinkles by paralyzing targeted muscles and to treat conditions such as muscle spasticity, migraines, and excessive sweating. In addition, they are utilized in research to study nerve function and the mechanisms of neuronal signaling, helping to advance the understanding of neurological disorders.

The major neurotoxin products include Botox, Dysport, Xeomin, and others. Botox is a neurotoxin derived from Clostridium botulinum bacteria and is used for both cosmetic and medical purposes to temporarily reduce wrinkles and manage certain muscular conditions. These products are applied in therapeutic and aesthetic settings by hospitals, specialty clinics, dermatology clinics, and other end users.

Tariffs have influenced the neurotoxin market by increasing costs for imported active pharmaceutical ingredients, biologics manufacturing equipment, and cold-chain logistics, impacting production economics and pricing strategies. These effects are most pronounced in therapeutic and aesthetic segments reliant on cross-border supply chains, with Asia-Pacific, Europe, and North America facing notable disruptions due to regulatory and trade dependencies. However, tariffs have also encouraged regional manufacturing, local sourcing of biologics, and investments in domestic production capabilities, supporting long-term supply chain resilience and market stability.

The neurotoxin market research report is one of a series of new reports from The Business Research Company that provides neurotoxin market statistics, including neurotoxin industry global market size, regional shares, competitors with a neurotoxin market share, detailed neurotoxin market segments, market trends and opportunities, and any further data you may need to thrive in the neurotoxin industry. This neurotoxin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurotoxin market size has grown strongly in recent years. It will grow from $8.03 billion in 2025 to $8.77 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to growing prevalence of aesthetic consciousness, increasing use of botulinum toxin in cosmetic procedures, rising incidence of neurological disorders, expansion of dermatology and specialty clinics, early regulatory approvals for botulinum-based products.

The neurotoxin market size is expected to see strong growth in the next few years. It will grow to $12.43 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to growth in therapeutic applications beyond cosmetics, rising demand for non-surgical medical treatments, innovation in next-generation neurotoxins, increasing healthcare expenditure in emerging markets, expanding aging population globally. Major trends in the forecast period include expansion of therapeutic neurotoxin indications, rising demand for minimally invasive aesthetic procedures, development of longer-lasting and precision neurotoxins, increasing adoption in chronic migraine and spasticity management, growing focus on safety, purity, and reduced immunogenicity.

The increasing use of cosmetic procedures to enhance physical appearance is expected to drive the growth of the neurotoxins market in the coming years. Cosmetic procedures encompass a broad range of medical treatments or interventions performed primarily to improve or modify an individual's physical appearance. This trend has been influenced by social, technological, and cultural factors, along with growing awareness of the benefits associated with cosmetic procedures. Neurotoxins are widely used in cosmetic treatments to relax targeted muscles and minimize the appearance of wrinkles and fine lines. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures rose by 7% in 2023, surpassing the growth rate of surgical procedures by 2%. Hand surgeries, including carpal tunnel, arthritis, and trigger finger procedures, accounted for 207,887 cases, representing a 2% increase compared to 2022. Therefore, the rising number of cosmetic procedures aimed at improving appearance is fueling the growth of the neurotoxins market.

Leading companies operating in the neurotoxins market are emphasizing innovative developments such as next-generation aesthetic neurotoxins to improve cosmetic results, broaden treatment choices, and enhance patient satisfaction. Next-generation aesthetic neurotoxins are newly developed botulinum-based formulations intended to deliver more accurate muscle modulation, quicker onset of action, or extended duration of effects for aesthetic wrinkle-reduction applications. For example, in January 2023, Evolus Inc., a US-based medical aesthetics company, received approval from the Australian Therapeutic Goods Administration (TGA) for Nuceiva (prabotulinumtoxinA). Nuceiva (prabotulinumtoxinA) is a neurotoxin used for aesthetic applications and is indicated to temporarily improve the appearance of moderate glabellar lines in adult patients by blocking nerve signals to facial muscles, causing them to relax and reducing wrinkles formed by facial expressions, squinting, and frowning.

In July 2023, Priveterra Acquisition Corp., a US-based special purpose acquisition company, acquired AEON Biopharma, Inc. for an undisclosed amount. This acquisition aims to create a publicly listed entity focused on advancing AEON's proprietary neurotoxin, ABP-450, which is being developed to treat serious conditions such as chronic migraines. The transaction includes plans to utilize up to $125 million in secured financing to support AEON's clinical development and commercialization activities, strengthening its position in the biopharmaceutical sector and contributing to growth in the neurosciences market. AEON Biopharma, Inc. is a US-based biopharmaceutical company engaged in the manufacturing of neurotoxins.

Major companies operating in the neurotoxin market are AbbVie Inc., Galderma Inc., Ipsen SA, Daewoong Pharmaceutical Co. Ltd., Merz Pharma GmbH & Co KGaA, Hugel Inc., Evolus Inc., Medytox Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., Gufic Biosciences Ltd., Hironic Co. Ltd., Allergan, Lanzhou Institute of Biological Products Co. Ltd., Sinclair Pharma, Vida Aesthetics, Evolife, Hugel Bio, Medytox USA, Revance Aesthetics

North America was the largest region in the neurotoxin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurotoxin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurotoxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurotoxin market consists of sales of lead, ethanol (drinking alcohol), glutamate, nitric oxide, tetanus toxin, and tetrodotoxin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurotoxin Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neurotoxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurotoxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurotoxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Botox; Dysport; Xeomin; Other Products
  • 2) By Application: Therapeutic; Aesthetic
  • 3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
  • Subsegments:
  • 1) By Botox: Cosmetic Uses; Therapeutic Uses
  • 2) By Dysport: Cosmetic Applications; Medical Indications
  • 3) By Xeomin: Cosmetic Treatments; Therapeutic Applications
  • 4) By Other Products: Jeuveau; Any Emerging Neurotoxins
  • Companies Mentioned: AbbVie Inc.; Galderma Inc.; Ipsen SA; Daewoong Pharmaceutical Co. Ltd.; Merz Pharma GmbH & Co KGaA; Hugel Inc.; Evolus Inc.; Medytox Inc.; Croma-Pharma GmbH; Revance Therapeutics Inc.; Gufic Biosciences Ltd.; Hironic Co. Ltd.; Allergan; Lanzhou Institute of Biological Products Co. Ltd.; Sinclair Pharma; Vida Aesthetics; Evolife; Hugel Bio; Medytox USA; Revance Aesthetics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Neurotoxin Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Neurotoxin Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Neurotoxin Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Neurotoxin Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Expansion Of Therapeutic Neurotoxin Indications
    • 4.2.2 Rising Demand For Minimally Invasive Aesthetic Procedures
    • 4.2.3 Development Of Longer-Lasting And Precision Neurotoxins
    • 4.2.4 Increasing Adoption In Chronic Migraine And Spasticity Management
    • 4.2.5 Growing Focus On Safety, Purity, And Reduced Immunogenicity

5. Neurotoxin Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Specialty Clinics
  • 5.3 Dermatology Clinics
  • 5.4 Neurology Clinics
  • 5.5 Cosmetic Surgery Centers

6. Neurotoxin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neurotoxin Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Neurotoxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Neurotoxin Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Neurotoxin Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Neurotoxin Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neurotoxin Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neurotoxin Market Segmentation

  • 9.1. Global Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Botox, Dysport, Xeomin, Other Products
  • 9.2. Global Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Therapeutic, Aesthetic
  • 9.3. Global Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Specialty Clinics, Dermatology Clinics, Other End Users
  • 9.4. Global Neurotoxin Market, Sub-Segmentation Of Botox, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cosmetic Uses, Therapeutic Uses
  • 9.5. Global Neurotoxin Market, Sub-Segmentation Of Dysport, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cosmetic Applications, Medical Indications
  • 9.6. Global Neurotoxin Market, Sub-Segmentation Of Xeomin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cosmetic Treatments, Therapeutic Applications
  • 9.7. Global Neurotoxin Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Jeuveau, Any Emerging Neurotoxins

10. Neurotoxin Market Regional And Country Analysis

  • 10.1. Global Neurotoxin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Neurotoxin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neurotoxin Market

  • 11.1. Asia-Pacific Neurotoxin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neurotoxin Market

  • 12.1. China Neurotoxin Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neurotoxin Market

  • 13.1. India Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neurotoxin Market

  • 14.1. Japan Neurotoxin Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neurotoxin Market

  • 15.1. Australia Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neurotoxin Market

  • 16.1. Indonesia Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neurotoxin Market

  • 17.1. South Korea Neurotoxin Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neurotoxin Market

  • 18.1. Taiwan Neurotoxin Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neurotoxin Market

  • 19.1. South East Asia Neurotoxin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neurotoxin Market

  • 20.1. Western Europe Neurotoxin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neurotoxin Market

  • 21.1. UK Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neurotoxin Market

  • 22.1. Germany Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neurotoxin Market

  • 23.1. France Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neurotoxin Market

  • 24.1. Italy Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neurotoxin Market

  • 25.1. Spain Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neurotoxin Market

  • 26.1. Eastern Europe Neurotoxin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neurotoxin Market

  • 27.1. Russia Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neurotoxin Market

  • 28.1. North America Neurotoxin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neurotoxin Market

  • 29.1. USA Neurotoxin Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neurotoxin Market

  • 30.1. Canada Neurotoxin Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neurotoxin Market

  • 31.1. South America Neurotoxin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neurotoxin Market

  • 32.1. Brazil Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neurotoxin Market

  • 33.1. Middle East Neurotoxin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neurotoxin Market

  • 34.1. Africa Neurotoxin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Neurotoxin Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neurotoxin Market Regulatory and Investment Landscape

36. Neurotoxin Market Competitive Landscape And Company Profiles

  • 36.1. Neurotoxin Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Neurotoxin Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Neurotoxin Market Company Profiles
    • 36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Galderma Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Ipsen SA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Daewoong Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Merz Pharma GmbH & Co KGaA Overview, Products and Services, Strategy and Financial Analysis

37. Neurotoxin Market Other Major And Innovative Companies

  • Hugel Inc., Evolus Inc., Medytox Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., Gufic Biosciences Ltd., Hironic Co. Ltd., Allergan, Lanzhou Institute of Biological Products Co. Ltd., Sinclair Pharma, Vida Aesthetics, Evolife, Hugel Bio, Medytox USA, Revance Aesthetics

38. Global Neurotoxin Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neurotoxin Market

40. Neurotoxin Market High Potential Countries, Segments and Strategies

  • 40.1 Neurotoxin Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Neurotoxin Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Neurotoxin Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer